Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Head and Neck Neoplasms × titanium silicide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 26 Pancreatic Neoplasms 7 Colorectal Neoplasms 7 Biliary Tract Neoplasms 4 Recurrence 2 Neoplasm Metastasis 2 Gastrointestinal Neoplasms 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Advanced Gastric Cancer 2 Rectal Neoplasms 1 Liver Diseases 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Bile Duct Neoplasms 1 Advanced Solid Tumors 1

Interventions

Cisplatin 207 Radiotherapy 165 Cetuximab 121 pembrolizumab 99 Fluorouracil 78 Docetaxel 76 Paclitaxel 67 Carboplatin 66 Radiotherapy, Intensity-Modulated 62 Surveys and Questionnaires 38 Nivolumab 38 Radiation 31 Drug Therapy 28 Blood Specimen Collection 24 Gemcitabine 22 Immunohistochemistry 20 Gefitinib 20 Erlotinib Hydrochloride 19 durvalumab 17 Surgical Procedures, Operative 17 Standard of Care 17 Magnetic Resonance Spectroscopy 17 Cyclophosphamide 17 Pemetrexed 15 atezolizumab 14 Low-Level Light Therapy 14 Gene Expression Profiling 14 Chemotherapy, Adjuvant 14 Biopsy 14 Bevacizumab 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01645748 2012-07-20

TPSHNSCC

Chonnam National University Hospital

Phase 2 Completed

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡